Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma L Masteller

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|August 17, 2002
Immunotherapy of insulin-dependent diabetes mellitusEmma L Masteller, Jeffrey A Bluestone
Drug Discovery Today|June 7, 2014
Targeting IL-34 in chronic inflammationEmma L Masteller, Brian R Wong
Seminars in Immunology|February 7, 2006
Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potentialEmma L Masteller, Qizhi Tang, Jeffrey A Bluestone
Protein Engineering|April 5, 2003
Directed evolution of a single-chain class II MHC product by yeast displayScott E Starwalt, Emma L Masteller, Jeffrey A Bluestone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic miceEmma L Masteller, Matthew R Warner, Qizhi Tang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetesEmma L Masteller, Matthew R Warner, Walter Ferlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2011
Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic miceEnayat Nikoopour, Christian Sandrock, Katrina Huszarik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreasYang D Dai, Kent P Jensen, Agnes Lehuen, et al.
The Journal of Experimental Medicine|June 9, 2004
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetesQizhi Tang, Kammi J Henriksen, Mingying Bi, et al.
Frontiers in Immunology|March 13, 2020
Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell ResponsesAmy Haseley Thorne, Kirsten N Malo, Ashley J Wong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|August 17, 2002
Immunotherapy of insulin-dependent diabetes mellitusEmma L Masteller, Jeffrey A Bluestone
Drug Discovery Today|June 7, 2014
Targeting IL-34 in chronic inflammationEmma L Masteller, Brian R Wong
Seminars in Immunology|February 7, 2006
Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potentialEmma L Masteller, Qizhi Tang, Jeffrey A Bluestone
Protein Engineering|April 5, 2003
Directed evolution of a single-chain class II MHC product by yeast displayScott E Starwalt, Emma L Masteller, Jeffrey A Bluestone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic miceEmma L Masteller, Matthew R Warner, Qizhi Tang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetesEmma L Masteller, Matthew R Warner, Walter Ferlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2011
Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic miceEnayat Nikoopour, Christian Sandrock, Katrina Huszarik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreasYang D Dai, Kent P Jensen, Agnes Lehuen, et al.
The Journal of Experimental Medicine|June 9, 2004
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetesQizhi Tang, Kammi J Henriksen, Mingying Bi, et al.
Frontiers in Immunology|March 13, 2020
Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell ResponsesAmy Haseley Thorne, Kirsten N Malo, Ashley J Wong, et al.
Pageof 2